Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
---|
01/19/2011 | EP1866429B1 Methods of islet isolation and transplantation |
01/19/2011 | EP1812014B1 Compositions and methods for prolonging survival of platelets |
01/19/2011 | EP1693456B1 Method of identifying modulators of a g protein-coupled receptor |
01/19/2011 | EP1664280B1 Skin regeneration system |
01/19/2011 | EP1649003B1 Methods of producing differentiated hematopoietic cells for treatment of cytopenia |
01/19/2011 | EP1492874B1 Multigenic vector plasmids and methods for increasing expression of recombinant polypeptides |
01/19/2011 | EP1363997B1 Concentration and lysis of adenovirus-infected cells in a single unit operation |
01/19/2011 | EP1302535B1 Heart muscle-like cell sheet, three-dimensional construct, heart muscle-like tissue and process for producing the same |
01/19/2011 | EP1276894B2 Method for screening of microorganisms under nutrient limited conditions |
01/19/2011 | EP1252300B1 Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon |
01/19/2011 | EP1132475B1 Novel serine protease bssp2 |
01/19/2011 | EP1027418B2 Cleaning compositions containing multiply-substituted protease variants |
01/19/2011 | CN1468304B Method of producing functional protein domains |
01/19/2011 | CN101952433A PTHrP, its isoforms and antagonist thereto in the diagnosis and treatment of disease |
01/19/2011 | CN101952428A Mutant pyrrolysyl-tRNA synthetase, and method for production of protein having non-natural amino acid integrated therein by using the same |
01/19/2011 | CN101952426A Anti-BST2 antibody |
01/19/2011 | CN101952420A Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same |
01/19/2011 | CN101952416A Methods for co-culturing cord blood derived cells with menstrual stem cells |
01/19/2011 | CN101952415A Differentiation of human embryonic stem cells |
01/19/2011 | CN101951940A Treatment of autoimmune disorders |
01/19/2011 | CN101949921A Heavy metal enzyme label and application thereof |
01/19/2011 | CN101948921A Application of NOB1 gene in treating brain glioma disease |
01/19/2011 | CN101948852A Piemarker epsps gene and application thereof |
01/19/2011 | CN101948850A Preparation method and application of virus-like particles of dengue viruses |
01/19/2011 | CN101948846A Polynucleotides and polypeptides involved in plant fiber development and methods of using same |
01/19/2011 | CN101948845A Optimization gene for coding chicken interferon alpha and application thereof in preparing chicken interferon alpha |
01/19/2011 | CN101948841A Epitope sequences |
01/19/2011 | CN101948819A Oxyneurin metabolic plant tyrosine phosphatase protein, coding gene thereof and use thereof |
01/19/2011 | CN101948818A N-acetyl homoserine lactonase-xylanase fusion protein and coding gene and application thereof |
01/19/2011 | CN101948808A Antibody capable of resisting heavy metal mercury ions and application thereof |
01/19/2011 | CN101948807A Heavy metal mercury ion antibody and application thereof |
01/19/2011 | CN101948806A Natural killer cell line modified by human interferon-alpha gene and establishing method thereof |
01/19/2011 | CN101948805A Double-signal transgenic cell sensor for screening chemopreventive agent and establishment method thereof |
01/19/2011 | CN101948804A Preparation method of umbilical cord mesenchymal stem cells |
01/19/2011 | CN101948803A Human epidermal derived mesenchymal stem cell-like pluripotent cells and preparation method thereof |
01/19/2011 | CN101948802A Method for sorting human articular cartilage CD105+/CD166+ mesenchymal stem cells by using immunomagnetic beads |
01/19/2011 | CN101948801A Serum-free culture medium supplement and preparation method thereof |
01/19/2011 | CN101948800A Giant salamander sperm protecting agent |
01/19/2011 | CN101948799A Method for improving developmental capacity of sheep mature oocytes after vitrification |
01/19/2011 | CN101948798A Method for separating and purifying human amniotic fluid-derived mesenchymal stemcells |
01/19/2011 | CN101948797A E.wushanense suspension cell culture system and establishment method and application thereof |
01/19/2011 | CN101948796A Method for extracting orange flesh chromoplast |
01/19/2011 | CN101948744A Cell vaccinating device of lumen-shaped matrix, vaccinating cavity and vaccinating method |
01/19/2011 | CN101948621A Inorganic crystal whisker strengthened keratin composite membrane and preparation method thereof |
01/19/2011 | CN101948546A Fusion protein SAmB as well as coding gene and applications thereof |
01/19/2011 | CN101948543A Fusion protein and coding gene and application thereof |
01/19/2011 | CN101948540A Preparation of novel anti-EGFR human source antibody MIL27 and application thereof |
01/19/2011 | CN101948539A IL-18 binding proteins |
01/19/2011 | CN101948533A Preparation method of fish skin collagen |
01/19/2011 | CN101948518A Method for preparing functional protein RJCPs by royal jelly and application |
01/19/2011 | CN101948517A Protein, gene and function fragment involved in palmitic acid synthesis and application thereof |
01/19/2011 | CN101948516A Establishment and application of vaccinia virus vector-based reverse genetics system |
01/19/2011 | CN101948512A Polypeptide WA8 for inhibiting type-2 shiga toxin activity and coding gene and application thereof |
01/19/2011 | CN101947241A Antioxidant preparation for protecting against vascular endothelial cell oxidative damage and preparation method thereof |
01/19/2011 | CN101502238B Micro-propagation method for Populus hybride |
01/19/2011 | CN101485293B Tissue culture, seedling cultivation and rooting method of Fructus schisandrae |
01/19/2011 | CN101463354B Brown planthopper resistant gene in rice and use thereof |
01/19/2011 | CN101327223B Medicament for treating osteonecrosis and cytoskeleton thereof |
01/19/2011 | CN101289514B Process for cultivating stress-tolerant plants and special DNA fragments thereof |
01/19/2011 | CN101116422B Root culture medium and the culture method in the purple leaf oxalis |
01/19/2011 | CN101100675B BIV indication cell line using enhanced green fluorescence protein as reporting gene |
01/18/2011 | US7872184 Plants and seeds of hybrid corn variety CH955795 |
01/18/2011 | US7872183 Plants and seeds of corn variety CV605722 |
01/18/2011 | US7872182 Plants and seeds of hybrid corn variety CH951965 |
01/18/2011 | US7872181 Plants and seeds of corn variety CV135273 |
01/18/2011 | US7872180 Maize variety PHHEB |
01/18/2011 | US7872179 Maize variety PHHKE |
01/18/2011 | US7872178 Plants and seeds of hybrid corn variety CH929154 |
01/18/2011 | US7872177 Plants and seeds of hybrid corn variety CH151527 |
01/18/2011 | US7872176 Soybean variety RJS54001 |
01/18/2011 | US7872175 Soybean variety XB05L09 |
01/18/2011 | US7871986 provides a prostate specific antigen oligo-epitope peptide (PSA-OP) that is useful as an immunogen in the prevention or treatment of prostatic cancer and in the inhibition of prostatic cancer cells and in the establishment and characterization of PSA-specific cytotoxic T-cell lines |
01/18/2011 | US7871815 producing a protein by cloning an open reading frame encoding a protein into the nucleic acid sequence of SEQ ID 151, introducing the resulting nucleic acid sequence into a host cell and exposing the host cell to rhamnose, thereby inducing expression of the protein |
01/18/2011 | US7871798 Mammalian cells that express VEGF-D polypeptides |
01/18/2011 | US7871797 proteolysis; recombinant vectors; transformants |
01/18/2011 | US7871786 Isolated nucleic acid encoding GEF-H1b polypeptide (Guanine nucleotide exchange factors); diagnosing abnormal cell proliferation and drug screening; measuring phosphorylation by p-21 activated kinase; antitumor agents, anticancer agents |
01/18/2011 | US7871763 gene expression; probes, primers, antibodies |
01/18/2011 | US7871638 Composite material containing a calcium phosphate gradient |
01/18/2011 | US7871606 Use of stimulated peripheral-blood mononuclear cells for the treatment of cancerous diseases |
01/18/2011 | US7871605 Mixed cell populations for tissue repair and separation technique for cell processing |
01/18/2011 | CA2594294C Plant-optimized genes encoding pesticidal toxins |
01/18/2011 | CA2496880C Methods for developing conifer somatic embryos |
01/18/2011 | CA2426107C Methods and compositions for tissue regeneration |
01/18/2011 | CA2418977C Gene delivery vectors with cell type specificity for primary human chondrocytes |
01/18/2011 | CA2385444C Humanin, a polypeptide suppressing neuronal death |
01/18/2011 | CA2383737C Muc-1 derived peptides |
01/18/2011 | CA2380537C An oncolytic adenovirus |
01/18/2011 | CA2301204C Sugarcane bacilliform virus promoter |
01/18/2011 | CA2192195C Modification of starch content in plants |
01/13/2011 | WO2011006073A1 Permanently charged sodium and calcium channel blockers as anti-inflammatory agents |
01/13/2011 | WO2011005974A2 Interpenetrating biomaterial matrices and uses thereof |
01/13/2011 | WO2011005930A1 Cardiac tissue-derived cells |
01/13/2011 | WO2011005849A1 Modified ips cells having a mutant form of human immunodeficiency virus (hiv) cellular entry gene |
01/13/2011 | WO2011005765A1 Bioprocessing |
01/13/2011 | WO2011005580A2 Adult animals generated from induced pluripotent cells |
01/13/2011 | WO2011005326A1 Methods and compositions for increased safety of stem cell-derived populations |
01/13/2011 | WO2011005306A2 Production of and uses for decellularized lung tissue |
01/13/2011 | WO2011004911A1 Method of inducing differentiation from pluripotent stem cells to skeletal muscle progenitor cells |
01/13/2011 | WO2011004847A1 NOVEL HUMANIZED ANTI-HUMAN α9-INTEGRIN ANTIBODY |
01/13/2011 | WO2011004837A1 Antibody having anti-cancer activity |